Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

Detalles Bibliográficos
Autores principales: Bieber, Thomas, Feist, Eugen, Irvine, Alan D., Harigai, Masayoshi, Haladyj, Ewa, Ball, Susan, Deberdt, Walter, Issa, Maher, Grond, Susanne, Taylor, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427552/
https://www.ncbi.nlm.nih.gov/pubmed/37347406
http://dx.doi.org/10.1007/s12325-023-02526-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427552/
https://www.ncbi.nlm.nih.gov/pubmed/37347406
http://dx.doi.org/10.1007/s12325-023-02526-w

Ejemplares similares